Drug
Mafosfamide clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 1990
How studies write it
Studies that test it under each name
Name
Studies by the year they started
2 studies that test it; most in 1990 (1)
| Year | Studies |
|---|---|
| 1990 | 1 |
| 2002 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 3
National Cancer Institute (NCI) (2) · Baylor College of Medicine (1)
Studies
Open first, then newest update. How each study uses mafosfamide is read from its arms, and is right about nine times in ten.
Testing it · 3
- Intrathecal MafosfamideCompletedPhase 1Baylor College of MedicineNCT00062881Written as Intrathecal Mafosfamide
- Mafosfamide in Treating Patients With Progressive or Refractory Meningeal TumorsCompletedPhase 1National Cancer Institute (NCI)NCT00031928Written as mafosfamide
- Phase I Study of Intrathecal MafosfamideCompletedPhase 1National Cancer Institute (NCI)NCT00001251Written as Mafosfamide
Codes
What other systems call mafosfamide · ClinicalTrials.gg INT003265
- MeSH (NLM) C048341mafosfamideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 5970HH9923MAFOSFAMIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q10322996mafosfamideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1150MafosfamideOne source FDA
- DrugBank DB12083One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C048341 | mafosfamide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 5970HH9923 | MAFOSFAMIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q10322996 | mafosfamide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1150 | Mafosfamide | One source FDA |
| DrugBank | DB12083 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.